Unilateral versus Bilateral Endoscopic Nasobiliary Drainage and Subsequent Metal Stent Placement for Unresectable Malignant Hilar Obstruction: A Multicenter Randomized Controlled Trial

Ryunosuke Hakuta, Hirofumi Kogure, Yousuke Nakai, Hiroshi Kawakami, Hiroyuki Maguchi, Tsuyoshi Mukai, Takuji Iwashita, Tomotaka Saito, Osamu Togawa, Saburo Matsubara, Tsuyoshi Hayashi, Iruru Maetani, Yukiko Ito, Osamu Hasebe, Takao Itoi, Keiji Hanada, Hiroyuki Isayama, Ryunosuke Hakuta, Hirofumi Kogure, Yousuke Nakai, Hiroshi Kawakami, Hiroyuki Maguchi, Tsuyoshi Mukai, Takuji Iwashita, Tomotaka Saito, Osamu Togawa, Saburo Matsubara, Tsuyoshi Hayashi, Iruru Maetani, Yukiko Ito, Osamu Hasebe, Takao Itoi, Keiji Hanada, Hiroyuki Isayama

Abstract

(1) Background: Endoscopic management of hilar biliary obstruction is still challenging. Compared with unilateral drainage, bilateral drainage could preserve larger functional liver volume and potentially improve clinical outcomes. To evaluate the effectiveness of bilateral drainage, we conducted this multicenter randomized controlled study. (2) Methods: Patients with unresectable malignant hilar biliary obstruction were assigned to unilateral or bilateral group. At first, patients underwent endoscopic nasobiliary drainage (ENBD), and subsequently underwent self-expandable metallic stent (SEMS) deployment. Primary outcomes were the functional success rate of ENBD and time to recurrent biliary obstruction (TRBO) after SEMS deployment. (3) Results: During the study period, 38 and 39 patients were enrolled in the unilateral and bilateral groups. The functional success rate was similar in the uni- and bi-ENBD group (57% vs. 56%; p = 0.99), but the rate of additional drainage was higher in uni-ENBD group. Although TRBO and overall survival time after SEMS deployment were not different between the groups (p = 0.11 and 0.78, respectively), the incidence of early adverse events tended to be higher in the bi-SEMS group (5.3% vs. 28%; p = 0.11). (4) Conclusions: Our study failed to demonstrate the superiority of bilateral over unilateral biliary drainage in terms of functional success rate and TRBO.

Keywords: cholestasis; endoscopic retrograde cholangiopancreatography; endoscopy; jaundice; stents.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Fluoroscopic images of endoscopic biliary drainage for hilar biliary obstruction. (A) Cholangiogram in a patient with hilar cholangiocarcinoma. (B) uncovered self-expandable metallic stents were deployed in a stent-in-stent fashion.
Figure 2
Figure 2
Flowchart of selection into uni- and bi-lateral endoscopic nasobiliary drainage group for patients with unresectable malignant hilar biliary obstruction. Bi-ENBD, bilateral endoscopic nasobiliary drainage; Bi-SEMS, bilateral self-expandable metallic stent; ENBD, endoscopic nasobiliary drainage; SEMS, self-expandable metallic stent; Uni-ENBD, unilateral endoscopic nasobiliary drainage; Uni-SEMS, unilateral self-expandable metallic stent.
Figure 3
Figure 3
Bilirubin decrease rates after unilateral (A) and bilateral (B) endoscopic nasobiliary drainage. The serum total bilirubin level was log-transformed, and bilirubin decrease rate was estimated using the nonlinear least-squares method (Step 1).
Figure 4
Figure 4
Kaplan–Meier curve of recurrent biliary obstruction (A) and overall survival (B) in the uni- and bi-SEMS group. p values were calculated using the log-rank test (Step 2). Bi-SEMS, bilateral self-expandable metallic stent; CI, confidence interval; NA, not available; OS, overall survival; SEMS, self-expandable metallic stent; TRBO, time to recurrent biliary obstruction; Uni-SEMS, unilateral self-expandable metallic stent.

References

    1. Adler D.G., Baron T.H., Davila R.E., Egan J., Hirota W.K., Leighton J.A., Qureshi W., Rajan E., Zuckerman M.J., Fanelli R., et al. ASGE guideline: The role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest. Endosc. 2005;62:1–8. doi: 10.1016/j.gie.2005.04.015.
    1. Lee T.H., Moon J.H., Park S. Biliary stenting for hilar malignant biliary obstruction. Dig. Endosc. 2020;32:275–286. doi: 10.1111/den.13549.
    1. Lee T.H., Kim T.H., Moon J.H., Lee S.H., Choi H.J., Hwangbo Y., Hyun J.J., Choi J.-H., Jeong S., Kim J.H., et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: A multicenter, prospective, randomized study (with video) Gastrointest. Endosc. 2017;86:817–827. doi: 10.1016/j.gie.2017.04.037.
    1. Ashat M., Arora S., Klair J.S., Childs C.A., Murali A.R., Johlin F.C. Bilateral vs unilateral placement of metal stents for inoperable high-grade hilar biliary strictures: A systemic review and meta-analysis. World J. Gastroenterol. 2019;25:5210–5219. doi: 10.3748/wjg.v25.i34.5210.
    1. Yasuda I., Mukai T., Moriwaki H. Unilateral versus bilateral endoscopic biliary stenting for malignant hilar biliary strictures. Dig. Endosc. 2013;25(Suppl. 2):81–85. doi: 10.1111/den.12060.
    1. Naitoh I., Ohara H., Nakazawa T., Ando T., Hayashi K., Okumura F., Okayama Y., Sano H., Kitajima Y., Hirai M., et al. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J. Gastroenterol. Hepatol. 2009;24:552–557. doi: 10.1111/j.1440-1746.2008.05750.x.
    1. Iwano H., Ryozawa S., Ishigaki N., Taba K., Senyo M., Yoshida K., Sakaida I. Unilateral versus Bilateral Drainage Using Self-Expandable Metallic Stent for Unresectable Hilar Biliary Obstruction. Dig. Endosc. 2010;23:43–48. doi: 10.1111/j.1443-1661.2010.01036.x.
    1. Vienne A., Hobeika E., Gouya H., Lapidus N., Fritsch J., Choury A.D., Chryssostalis A., Gaudric M., Pelletier G., Buffet C., et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: The role of liver volume assessment. Gastrointest. Endosc. 2010;72:728–735. doi: 10.1016/j.gie.2010.06.040.
    1. De Palma G.D., Galloro G., Siciliano S., Iovino P., Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: Results of a prospective, randomized, and controlled study. Gastrointest. Endosc. 2001;53:547–553. doi: 10.1067/mge.2001.113381.
    1. Staub J., Siddiqui A., Murphy M., Lam R., Parikh M., Pleskow D., Papachristou G., Sharaiha R., Iqbal U., Loren D., et al. Unilateral versus bilateral hilar stents for the treatment of cholangiocarcinoma: A multicenter international study. Ann. Gastroenterol. 2020;33:202–209. doi: 10.20524/aog.2020.0451.
    1. Cassani L.S., Chouhan J., Chan C., Lanke G., Chen H.-C., Wang X., Weston B., Ross W.A., Raju G.S., Lee J.H. Biliary Decompression in Perihilar Cholangiocarcinoma Improves Survival: A Single-Center Retrospective Analysis. Dig. Dis. Sci. 2019;64:561–569. doi: 10.1007/s10620-018-5277-z.
    1. Mukai T., Yasuda I., Nakashima M., Doi S., Iwashita T., Iwata K., Kato T., Tomita E., Moriwaki H. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: A randomized controlled trial. J. Hepato-Biliary-Pancreat. Sci. 2012;20:214–222. doi: 10.1007/s00534-012-0508-8.
    1. Fujita T., Hashimoto S., Tanoue S., Tsuneyoshi K., Nakamura Y., Hinokuchi M., Iwaya H., Arima S., Iwashita Y., Sasaki F., et al. Factors Associated with the Technical Success of Bilateral Endoscopic Metallic Stenting with Partial Stent-In-Stent Placement in Patients with Malignant Hilar Biliary Obstruction. Gastroenterol. Res. Pract. 2019;2019:1–7. doi: 10.1155/2019/5928040.
    1. Lee T.H., Moon J.H., Kim J.H., Park D.H., Lee S.S., Choi H.J., Cho Y.D., Park S.H., Kim S.J. Primary and revision efficacy of cross-wired metallic stents for endoscopic bilateral stent-in-stent placement in malignant hilar biliary strictures. Endoscopy. 2012;45:106–113. doi: 10.1055/s-0032-1325928.
    1. Kogure H., Isayama H., Nakai Y., Tsujino T., Matsubara S., Yashima Y., Ito Y., Tsuyoshi H., Takahara N., Miyabayashi K., et al. High single-session success rate of endoscopic bilateral stent-in-stent placement with modified large cell Niti-S stents for malignant hilar biliary obstruction. Dig. Endosc. 2014;26:93–99. doi: 10.1111/den.12055.
    1. Kogure H., Isayama H., Kawakubo K., Sasaki T., Yamamoto N., Hirano K., Sasahira N., Tsujino T., Tada M., Koike K. Endoscopic bilateral metallic stenting for malignant hilar obstruction using newly designed stents. J. Hepato-Biliary-Pancreat. Sci. 2011;18:653–657. doi: 10.1007/s00534-011-0407-4.
    1. Kawakami H., Kuwatani M., Onodera M., Haba S., Eto K., Ehira N., Yamato H., Kudo T., Tanaka E., Hirano S., et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J. Gastroenterol. 2010;46:242–248. doi: 10.1007/s00535-010-0298-1.
    1. Kawakubo K., Kawakami H., Kuwatani M., Haba S., Kudo T., A Taya Y., Kawahata S., Kubota Y., Kubo K., Eto K., et al. Lower incidence of complications in endoscopic nasobiliary drainage for hilar cholangiocarcinoma. World J. Gastrointest. Endosc. 2016;8:385–390. doi: 10.4253/wjge.v8.i9.385.
    1. Isayama H., Hamada T., Yasuda I., Itoi T., Ryozawa S., Nakai Y., Kogure H., Koike K. TOKYO criteria 2014 for transpapillary biliary stenting. Dig. Endosc. 2015;27:259–264. doi: 10.1111/den.12379.
    1. Cotton P.B., Eisen G.M., Aabakken L., Baron T.H., Hutter M.M., Jacobson B.C., Mergener K., Nemcek A., Petersen B.T., Petrini J.L., et al. A lexicon for endoscopic adverse events: Report of an ASGE workshop. Gastrointest. Endosc. 2010;71:446–454. doi: 10.1016/j.gie.2009.10.027.
    1. Suda K., Ohtsuka M., Ambiru S., Kimura F., Shimizu H., Yoshidome H., Miyazaki M. Risk factors of liver dysfunction after extended hepatic resection in biliary tract malignancies. Am. J. Surg. 2009;197:752–758. doi: 10.1016/j.amjsurg.2008.05.007.
    1. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2012;48:452–458. doi: 10.1038/bmt.2012.244.
    1. Yang M.J., Kim J.H., Hwang J.C., Yoo B.M., Lee S.H., Ryu J.K., Kim Y.-T., Woo S.M., Lee W.J., Jeong S., et al. Prospective Multicenter Study of the Challenges Inherent in Using Large Cell-Type Stents for Bilateral Stent-in-Stent Placement in Patients with Inoperable Malignant Hilar Biliary Obstruction. Gut Liver. 2018;12:722–727. doi: 10.5009/gnl17468.
    1. Lee T.H., Moon J.H., Choi J.-H., Lee S.H., Lee Y.N., Paik W.H., Jang D.K., Cho B.W., Yang J.K., Hwangbo Y., et al. Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture. Gastrointest. Endosc. 2019;90:222–230. doi: 10.1016/j.gie.2019.03.011.
    1. Ishigaki K., Hamada T., Nakai Y., Isayama H., Sato T., Hakuta R., Saito K., Saito T., Takahara N., Mizuno S., et al. Retrospective Comparative Study of Side-by-Side and Stent-in-Stent Metal Stent Placement for Hilar Malignant Biliary Obstruction. Dig. Dis. Sci. 2020;65:3710–3718. doi: 10.1007/s10620-020-06155-z.
    1. Miura S., Kanno A., Masamune A., Hamada S., Hongou S., Yoshida N., Nakano E., Takikawa T., Kume K., Kikuta K., et al. Risk factors for recurrent biliary obstruction following placement of self-expandable metallic stents in patients with malignant perihilar biliary stricture. Endoscopy. 2016;48:536–545. doi: 10.1055/s-0042-102651.
    1. Inoue T., Ibusuki M., Kitano R., Kobayashi Y., Ohashi T., Nakade Y., Sumida Y., Ito K., Yoneda M. Endobiliary radiofrequency ablation combined with bilateral metal stent placement for malignant hilar biliary obstruction. Endoscopy. 2020;52:595–599. doi: 10.1055/a-1133-4448.
    1. Kongkam P., Tasneem A.A., Rerknimitr R. Combination of endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography-guided biliary drainage in malignant hilar biliary obstruction. Dig. Endosc. 2019;31(Suppl. 1):50–54. doi: 10.1111/den.13371.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere